Correlation between tumor extent in radical prostatectomies and preoperative PSA, histological grade, surgical margins, and extraprostatic extension: Application of a new practical method for tumor extent evaluation

International Braz J Urol

Volumn 29, Issue 2, 2003, Pages 113-120

  Billis, Athanase ^a   Magna, Luís A ^a   Ferreira, Ubirajara ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Classification; Pathology; Prostate; Prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ARTICLE; CANCER CLASSIFICATION; CANCER GRADING; CANCER INVASION; CONTROLLED STUDY; CORRELATION ANALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE EVALUATION; PROGNOSIS; PROSTATE ADENOCARCINOMA; PROSTATECTOMY; SEMINAL VESICLE; STATISTICAL DISTRIBUTION; STATISTICAL SIGNIFICANCE; SURGICAL TECHNIQUE; TUMOR VOLUME;

EID: 0037853329     PISSN: 16775538     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1677-55382003000200004     Document Type: Article

References (23)

1. McNeal JE: Cancer volume and site of origin of adenocarcinoma in the prostate: relationship to local and distant spread. Hum Pathol. 1992; 23: 258-66.
2. Epstein JI: Pathologic assessment of the surgical specimen. Urol Clin North Am. 2001; 28: 567-94.
3. Bostwick DG, Montironi R: Evaluating radical prostatectomy specimens: therapeutic and prognostic importance. Virchows Arch. 1997; 430: 1-16.
4. Cantrell BB, DeKlerk DP, Eggleston JC, Boitnott JK, Walsh PC: Pathologic factors that influence prognosis in stage A prostatic cancer: The influence of extent versus grade. J Urol. 1981; 125: 516-20.
5. Humphrey PA, Vollmer RT: Percentage carcinoma as a measure of prostatic tumor size in radical prostatectomy tissues. Mod Pathol. 1997; 10: 326-33.
6. Renshaw AA, Chang H, D'Amico AV: Estimation of tumor volume in radical prostatectomy specimens in routine clinical practice. Am J Clin Pathol. 1997; 107: 704-8.
7. Renshaw AA, Richie JR, Loughlin KR, Jiroutek M, Chung A, D'Amico AV: Maximum diameter of prostatic carcinoma is a simple, inexpensive, and independent predictor of prostate-specific antigen failure in radical prostatectomy specimens. Am J Clin Pathol. 1999; 111: 641-4.
8. Mostofi FK, Price EB Jr: Tumors of the Male Genital System, Atlas of Tumor Pathology, Second Series, Fascicle 8. Washington DC, Armed Forces Institute of Pathology. 1973; pp. 202-17.
9. Gleason DF, Mellinger GT and the Veterans Administration Cooperative Urological Research Group: Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. J Urol. 1974; 111: 58-64.
10. Gleason DF: Histologic grading of prostate cancer: A perspective. Hum Pathol. 1992; 23: 273-9.
11. Epstein JI, Carmichael M, Walsh PC: Adenocarcinoma of the prostate invading the seminal vesicle: definition and relation of tumor volume, grade and margins of resection to prognosis. J Urol. 1993; 149: 1040-5.
12. International Union Against Cancer: Prostate. In: Sobin LH, Wittekind Ch. (eds.), TNM Classification of Malignant Tumors, 6th ed. New York, Wiley-Liss. 2002; pp. 184-7.
13. Bostwick DG, Montironi E: Evaluating radical prostatectomy specimens: therapeutic and prognostic importance. Virchows Arch. 1997; 430: 1-16.
14. Humphrey PA, Vollmer RT: Intraglandular tumor extent and prognosis in prostatic carcinoma: Application of a grid method to prostatectomy specimens. Hum Pathol. 1990; 21: 799-804.
15. Carvalhal GF, Humphrey PA, Thorson P, Yan Y, Ramos CG, Catalona WJ: Visual estimate of the percentage of carcinoma is an independent predictor of prostate carcinoma recurrence after radical prostatectomy. Cancer. 2000; 89: 1308-14.
16. Humphrey A, Vollmer RT: The ratio of prostate chips with cancer: A new measure of tumor extent and its relationship to grade and prognosis. Hum Pathol. 1988; 19: 411-8.
17. McNeal JE, Bostwick DG, Kindrachuk RA, Redwine EA, Freiha FS, Stamey TA: Patterns of progression in prostate cancer. Lancet 1986; 1: 60-3.
18. Epstein JI, Oesterling JE, Walsh PC: Tumor volume versus percentage of specimen involved by tumor correlated with progression in stage A prostatic carcinoma. J Urol. 1988; 139: 980-4.
19. Partin AW, Epstein JI, Cho KR, Gillelsohn AM, Walsh PC: Morphometric measurement of tumor volume and per cent of gland involvement as predictors of pathological stage in clinical stage B prostate cancer. J Urol. 1989; 141: 341-5.
20. McNeal JE, Price HM, Redwine EA, Freiha FS, Stamey TA: Stage A versus stage B adenocarcinoma of the prostate: Morphological comparison and biological significance. J Urol. 1988; 139: 61-5.
21. Herman CM, Kattan MW, Ohori M, Scardino PT, Wheeler TM: Primary Gleason pattern as a predictor of disease progression in Gleason score 7 prostate cancer: a multivariate analysis of 823 men treated with radical prostatectomy. Am J Surg Pathol. 2001; 25: 657-60.
22. Lau WK, Blute ML, Bostwick DG, Weaver AL, Sebo TJ, Zincke H: Prognostic factors for survival of patients with pathological Gleason score 7 prostate cancer: differences in outcome between primary Gleason grades 3 and 4. J Urol. 2001; 166: 1692-7.
23. Epstein JI, Carmichael M, Partin AW, Walsh PC: Is tumor volume an independent predictor of progression following radical prostatectomy? A multivariate analysis of 185 clinical stage B adenocarcinoma of the prostate with 5 years of follow-up. J Urol. 1993; 149: 1478-85.